Biotech stocks have been hammered back to back for two years in a row now. The last time the SPDR ETF suffered a drop of 15% or more was in 2018, and the fund followed it up with a 33% increase in 2019. It dropped more than 15% in 2016 and followed that up with […]
ABBV
AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market
Technavio has reported that Abbie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd could benefit the female infertility drug market growth. Technavio expects North America to play a vital role in increasing the market. Calculations show that the region could account for 35% growth. Despite this, Europe and Asia will experience faster growth. Between 2020 and […]
Abbott Laboratories (NYSE:ABT) May Face Legal Action – ABBV
Boston, MA 10/24/2013 (wallstreetpr) – An investigation has been launched by a law firm into potential violations of securities laws concerning the demerger of Abbott Laboratories (NYSE:ABT) and AbbVie Inc (NYSE:ABBV). Abbott had announced the demerger in October 2011 as the businesses had evolved in two separate entities. Abbott would continue to focus on drug manufacturing and […]
